NVDA

174.77

-1.35%↓

AAPL

252.12

+0.26%↑

MSFT

375.27

-2.53%↓

TSM

340.64

+0.59%↑

AVGO.US

316.7

-1.93%↓

NVDA

174.77

-1.35%↓

AAPL

252.12

+0.26%↑

MSFT

375.27

-2.53%↓

TSM

340.64

+0.59%↑

AVGO.US

316.7

-1.93%↓

NVDA

174.77

-1.35%↓

AAPL

252.12

+0.26%↑

MSFT

375.27

-2.53%↓

TSM

340.64

+0.59%↑

AVGO.US

316.7

-1.93%↓

NVDA

174.77

-1.35%↓

AAPL

252.12

+0.26%↑

MSFT

375.27

-2.53%↓

TSM

340.64

+0.59%↑

AVGO.US

316.7

-1.93%↓

NVDA

174.77

-1.35%↓

AAPL

252.12

+0.26%↑

MSFT

375.27

-2.53%↓

TSM

340.64

+0.59%↑

AVGO.US

316.7

-1.93%↓

Search

Synaptics Inc

Uždarymo kaina

SektoriusTechnologijų sektorius

72.6 2.85

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

70.59

Max

75.28

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-17M

-37M

Pardavimai

10M

303M

P/E

Sektoriaus vid.

14.82

77.27

Pelnas, tenkantis vienai akcijai

1.21

Pelno marža

-12.298

Darbuotojai

1,700

EBITDA

6M

27M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+44.16% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-413M

2.9B

Ankstesnė atidarymo kaina

69.75

Ankstesnė uždarymo kaina

72.6

Naujienos nuotaikos

By Acuity

12%

88%

13 / 376 reitingas Technology

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Synaptics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Synaptics Inc Prognozė

Kainos tikslas

By TipRanks

44.16% į viršų

12 mėnesių prognozė

Vidutinis 102.4 USD  44.16%

Aukščiausias 125 USD

Žemiausias 80 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Synaptics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

9

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

56.13 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

13 / 376 reitingas Technologijų sektorius

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Synaptics Inc

Synaptics Incorporated develops, markets, and sells semiconductor products worldwide. It offers wireless connectivity solutions comprising Wi-Fi, Bluetooth, Bluetooth Low Energy, Zigbee, Thread, Matter, global positioning system, global navigation satellite system, and ULE; Astra, an AI solutions; ultra-low power edge artificial intelligence platform for battery powered wireless devices; and voice over IP for developing affordable, scalable and power efficient VoIP, home and office products; AudioSmart for voice and audio processing; DisplayLink for transmitting compressed video frames across low bandwidth connections; and ConnectSmart for high-speed video/audio/data connectivity. The company also provides Natural ID, a fingerprint ID product for notebook personal computers (PCs), PC peripherals, automobiles, and other applications; TouchPad, a touch-sensitive pad that senses the position and movement of one or more fingers on its surface; ClearPad that enables users to interact directly with the display on electronic devices; ClearView display driver that offers advanced image processing and low power technology for displays on electronic devices; and TouchView products, a touch controller and display driver integration product. In addition, it offers fax, modem and image processors and software solutions for printers, fax machines, point of sale terminals, and medical applications. The company sells its products through direct sales, outside sales representatives, distributors, and value-added resellers to mobile and PC OEMs; IoT OEMs; and automotive and consumer electronics manufacturers. Synaptics Incorporated was incorporated in 1986 and is headquartered in San Jose, California.
help-icon Live chat